Brief: Avita Medical Announces FDA 510(K) Clearance For Cohealyx, Expanding Its Addressable Market
19/12/2024 22:07
Dec 19 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL ANNOUNCES FDA 510(K) CLEARANCE FOR COHEALYX,
EXPANDING ITS ADDRESSABLE MARKET
* AVITA MEDICAL INC - TO DEVELOP CLINICAL DATA FOR COHEALYX
IN
EARLY 2025
Source text: ID:nGNXcdGBhY
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing